Dapagliflozin to Prevent the Incidence of Contrast Induced Nephropathy After Heart Catheterization and Percutaneous Coronary Intervention

Clinical trial NCT04806633 · UNKNOWN

Trial details

NCT number: NCT04806633
Sponsor: G.Gennimatas General Hospital
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Left Cardiac Catheterization Percutaneous Coronary Intervention Acute Kidney Injury Sodium-glucose Co-transporter 2 Inhibitors

Start date: 2021-04-01
Primary completion: 2023-09-01
Enrollment: 1722

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.